TABLE 2.
Coverage of invasive cases by hypothetical and established pneumococcal vaccine formulations
| Vaccine formulation type and coverage (vaccine serotypes)a | Coverage of invasive cases (%) |
|---|---|
| Hypothetical | |
| 7-valent (6, 19F, 16F, 13, 34, 37, 14) | 22.3 |
| 9-valent (6, 19F, 16F, 13, 34, 37, 14, 15C, 23F) | 25.7 |
| 11-valent (6, 19F, 16F, 13, 34, 37, 14, 15C, 23F, 15B, 33F) | 29.5 |
| Established | |
| 7-valent (4, 14, 18C, 19F, 23F, 6B, 9V) | 26.1 |
| 9-valent (1, 4, 5, 14, 18C, 19F, 23F, 6B, 9V) | 43.1 |
| 11-valent (1, 3, 4, 5, 7F, 14, 18C, 19F, 23F, 6B, 9V) | 47.7 |
a
Hypothetical vaccines are based on carriage strains. Vaccine serotype 6 is 6A plus 6B.